Profit before tax for the quarter stood at Rs 118.58 crore, up 10.45% from Rs 107.36 crore in Q1 FY23.

Reported EBITDA (Including other income) grew by 12.4% year on year to Rs 160.2 crore in the quarter ended 30 June 2023.

EBITDA margin reduced to 25.5% in Q1 FY24 as compared to 26.5% recorded in Q1 FY23.

On operational front, In patient (IP) volumes stood at Rs 46,205 (up 16.5% YoY), Out patient (OP) volumes was at Rs 3,82,387 (up 17.7% YoY), average revenue per operating bed (ARPOB) stood at Rs 31,697 (up 5% YoY), average revenue per patient (ARPP) was at Rs 1,31,363 (up 5% YoY).

During the quarter, bed occupancy improved to 70.4% as against 65.5% reported in the same period a year ago.

Cash and cash equivalents came in at Rs 178 crore in Q1 FY24. Net debt to equity ratio stood at 0.22 during the period under review.

Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said, “Despite it being a seasonally lean quarter, we have done reasonably well on key parameters. We continue to focus on two critical parameters: Clinical Excellence and Affordable Quality Care. I am optimistic that we are on track to meet our targets for FY 24.”

Headquartered in Hyderabad, KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. It has a network of 12 hospitals and 3940 beds spread across Telangana, Andhra Pradesh and Maharashtra.

Shares of Krishna Institute of Medical Sciences declined 0.50% to Rs 1,845.60 on the BSE.